Ferring Pharmaceuticals today announced changes to the company’s Board of Directors. Effective immediately, Alexandra, Countess of Frederiksborg will become a new non-executive member of the Board…

New data presented today at the European Society of Human Reproduction and Embryology (ESHRE) 2007 congress shows that…

Medical, political and demographical experts drawn from across the globe have come together this week to discuss the ongoing challenges associated with access to infertility…

Ferring Pharmaceuticals and Shanghai Dongbao Biopharmaceutical Company announced today the signing of an agreement by which Dongbao Biopharmaceutical will purchase Ferring’s manufacturing operation at Malmö in Sweden…

Speaking today at a Ferring-sponsored symposium on the occasion of the 14th United European Gastroenterology…

Ferring Pharmaceuticals, the pioneering Swiss pharmaceutical group and world leader in industrial synthesis of peptides, today officially opens its new production site and administrative Headquarters in Saint-Prex in the canton of Vaud…

New research conducted by the independent ‘think tank’ RAND Europe discusses one potential solution to the population ageing crisis in Europe that has not yet been considered…

Following the presentation today of the results of the Phase IIb programme with degarelix in prostate cancer, which are in line with previous promising studies, Ferring Pharmaceuticals announced the immediate start of Phase III trials…

Ferring Pharmaceuticals (“Ferring”; headquarters: Lausanne, Switzerland; executive chairman: Frederik Paulsen) and Astellas Pharma Inc….